Management of schizophrenia with obsessive-compulsive disorder

Psychiatric Annals

Volumn 35, Issue 1, 2005, Pages 36-43

  Hwang, Michael Y ^a,b   Yum, Sun Young ^c   Kwon, Jun Soo ^d   Opler, Lewis A ^e  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d Seoul National University   (South Korea)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; FLUOXETINE; FLUPHENAZINE DECANOATE; FLUVOXAMINE; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; NEUROLEPTIC AGENT; NORFLUOXETINE; OLANZAPINE; PAROXETINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

AGITATION; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; ELECTROCONVULSIVE THERAPY; HALLUCINATION; HUMAN; HYPERACTIVITY; IMPULSIVENESS; INSTITUTIONALIZATION; LONG TERM CARE; LOW DRUG DOSE; MENTAL HEALTH; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; PARANOID SCHIZOPHRENIA; PARKINSONISM; PREVALENCE; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; RESTLESSNESS; REVIEW; SCHIZOPHRENIA; SELF CARE; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT INDICATION;

EID: 13244278116     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Hwang MY, Bermanzohn PC, eds. Schizophrenia and Comorbid Conditions: Diagnosis and Treatment. Washington, DC: American Psychiatric Publishing; 2001.
2. Westphal K. Ueber zwangsvorstellungen. Archiv Fur psychiatrie und Nervenkrankheiten. 1878;8:734-750.
3. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: Livingstone Press; 1919.
4. Freud S. Further recommendations in the technique of psychoanalysis. Collected papers. London, England: Hogarth Press; 1957:342-365.
5. Stengel E. A study on some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. J Ment Sci. 1945;91:166-184.
6. Rosen I. The clinical significance of obsessions in schizophrenia. J Ment Sci. 1957;103:778-785.
7. Fenton WS, McGlashan TH. The prognostic significance of obsessive-compulsive symptoms in schizophrenia. Am J Psychiatry. 1986;143(4):437-441.
8. Hwang MY, Morgan JE, Losonczy MF. Clinical and neuropsychological profiles of Obessive-Compulsive schizophrenia: a pilot study. J Neuropsychiatry Clin Neurosci. 2000;12(1):91-94.
9. Samuels J, Nestadt G, Wolyniec P, et al. Obsessive-compulsive symptoms in schizophrenia. Schizophrenia Res. 1993;9:139.
10. Poyurovsky M, Kriss V, Weisman G, et al. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. J Clin Psychiatry. 2003;64(11):1300-1307
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiaric Publishing; 1980.
12. Foa EB, Kozak MJ, Goodman WK, et al. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry. 1995;152(1):90-96.
13. Solyom L, DiNicola VF, Phil M, Sookman D, Luchins D. Is there an obsessive psychosis? Aetiological and prognostic factors of an atypical form of obsessive compulsive neurosis. Can J Psychiatry. 1985;30(5):372-380.
14. Insel TR, Akiskal HS. Obsessive-compulsive disorder with psychotic features: a phenomenological analysis. Am J Psychiatry. 1986;143(12):1527-1533.
15. Bermanzohn PC, Porto L, Arlow PB, et al. Obsessions and delusions: separate and distinct or overlapping? CNS Spectrums. 1997;2(3):58-61.
16. Jahrreiss W. Obsessions during schizophrenia. Arch Psychiatry. 1926;77:740-788.
17. Bland RC, Newman SC, Orn H. Schizophrenia: Lifetime comorbidity in a community sample. Acta Psychiatr Scand. 1987;75(4):383-391.
18. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45(12):1094-1099.
19. Stoll AL, Tohen M, Baldessarini R. Increasing frequency of the diagnosis of obsessive compulsive disorder. Am J Psychiatry. 1992;149(5):638-640.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiaric Publishing; 1994.
21. Craig T, Hwang MY, Bromet EJ. Obsessive-compulsive and panic Symptoms in patients with first-admission psychosis. Am. J. Psychiatry. 2002;159(4):592-598.
22. Hwang MY, Opler LA. Schizophrenia with obsessive-compulsive features: assessment and treatment. Psychiatr Ann. 1994;24:468-472.
23. Hwang MY, Martin AM, Lindenmayer JP, Stein D, Hollander E. Treatment of schizophrenia with obsessive-compulsive features with serotonin reuptake inhibitors. Am J Psychiatry. 1993;150(7):1127.
24. Hwang MY, Rho J, Opler LA, et al. Treatment of obsessive-compulsive schizophrenic patient with clomipramine: clinical and neuropsychological findings. Neuropsychiatry, Neuropsychology and Behavioral Neurology. 1995:8(3)231-233.
25. Sasson Y, Bermanzohn PC, Zohar J. Treatment of obsessive-compulsive syndromes in schizophrenia CNS Spectrums. 1997;2(4):34-45.
26. Berman I, Sapers BL, Chang HHJ, et al. Treatment of obsessive-compulsive syptoms in schizophrenic patient with clomipramine. J Clin Psychopharmacol. 1995;15:206-210.
27. Patil B, Tandon R. Development of obsessive-compulsive symptoms during clozapine treatment. Am J Psychiatry. 1993;150:836.
28. Lindenmayer JP, Vakharia M, Kanofsky D. Fluoxetine in chronic schizophrenia. J Clin Psychopharmacol. 1990;10(1):76.
29. Bark N, Lindenmayer JP. Ineffectiveness of clomipramine for obsessive-compulsive symptoms in patients with schizophrenia. Am J Psychiatry. 1992;149(1)136-137.
30. Baker RW, Bermanzohn PC, Wirsching DA, Chengappa KNR. Obsessions, compulsions, clozapine and risperidone. CNS Spectrums. 1997;2(3):26-36.
31. Allen L, Tejera C. Treatment of clozapine induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry. 1994;151(7):1096-1097.
32. Ghaemi SN, Zarate CA, Popli AP, Pillay SS, Cole JO. Is there relationship between clozapine and obsessive compulsive disorder? A retrospective chart review. Compr Psychiatry. 1995;36(4):267-270.
33. McDougle CJ, Fleischmann RL, Epperson CN, et al. Risperidone addition in fluvoxamine refractory obsessive-compulsive disorder: three cases. J Clin Psychiatry. 1995;56(11):526-528.
34. Goodman W, Price L, Rasmussen S, et al. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011.
35. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276.
36. Ciraulo DA, Shader RI. Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics. J Clin Psychopharmacol. 1990;10(1):48-50.
37. Goff DC, Midha KK, Brotman AW, Waites M, Baldessarini RJ. Elevation of plasma concentration of haloperidol after the addition of fluoxetine. Am J Psychiatry. 1991;148(6):790-792.
38. Zohar J. Is there room for another diagnostic subtype - the schizoobsessive subtype? CNS Spectrums. 1997;2(3):49-50.